← All companies

ICU

SeaStar Medical Holding Corporation

ICU Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$3.20

+0.01 +0.47%

Key statistics

from XBRL data in SEC filings

Market cap

$12.8M

Revenue (TTM)

$1.44M

Net income (TTM)

-$11.9M

EPS (TTM)

$-6.32

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$6.30M

Total assets

$11.3M

Gross margin

93.1%

52-week range

$2.07 – $12.50

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 1, 2026 8-K/A Director or officer change Jun 23, 2026 8-K Director or officer change; Shareholder vote results Jun 17, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Other events Apr 28, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 8-K Results of operations (earnings release) Mar 25, 2026 8-K Other events Jan 20, 2026 8-K/A Modified rights of security holders; Other events Dec 23, 2025 8-K Modified rights of security holders; Shareholder vote results Dec 18, 2025 8-K Director or officer change Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Director or officer change Sep 29, 2025 8-K Other events Sep 24, 2025 8-K Director or officer change Aug 19, 2025 8-K/A Results of operations (earnings release) Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Completed an acquisition or disposition Aug 13, 2025 8-K Other events Aug 8, 2025 8-K/A Delisting notice or listing-rule failure Aug 6, 2025 8-K Delisting notice or listing-rule failure Aug 6, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Aug 1, 2025 8-K Director or officer change Jul 16, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jul 14, 2025 8-K Shareholder vote results Jul 8, 2025 8-K Regulation FD disclosure; Other events Jul 2, 2025 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure; Other events Jun 23, 2025 8-K Director or officer change Jun 11, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Entered a material agreement; Unregistered sale of equity Apr 25, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 23, 2025 8-K Shareholder vote results Mar 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Shareholder vote results Mar 21, 2025 8-K Other events Mar 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Feb 3, 2025